About this file

This document is an amendment to Solicitation HT9402-24-Q-9401 issued by the Defense Health Agency (DHA). The amendment extends the Request for Quote (RFQ) due date for the November 2024 P&T drug classes from September 12, 2024 to September 19, 2024. The RFQ covers pharmaceutical agents in the following drug classes: Migraine Agents: Oral CGRP, Targeted Immunomodulatory Biologics: Interleukin 17, and Targeted Immunomodulatory Biologics: Interleukin 23. The DHA may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the Uniform Formulary decisions. A pre-quote teleconference is scheduled for July 24, 2024, and responses to the clinical questions are due by the date stated in Part 2.4.

View the file

Other files

File Type Posted
Amend 0002 RFQ HT9402-24-Q-9401.pdf PDF
Amendment 0001.pdf PDF
Amend 0001 November 2024 PT Meeting Reporting.xlsx XLSX spreadsheet
NDC Price List - TIBS - IL 23.xlsx XLSX spreadsheet
NDC Price List - TIBS - IL 17.xlsx XLSX spreadsheet
November 2024 PT Meeting Reporting.xlsx XLSX spreadsheet
NDC Price List - Migraine Agents - Oral CGRP.xlsx XLSX spreadsheet
RFQ HT9402-24-Q-9401 CR.pdf PDF
NDC Price List FAQ Class Review.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

DEFENSE HEALTH AGENCY

7700 ARLINGTON BOULEVARD, SUITE 5101 FALLS

CHURCH, VIRGINIA 22042-5101

HT9402-24-Q-9401 0002

September 9, 2024

SUBJECT: Amendment to Solicitation HT9402-24-Q-9401 For Quote Due Date Extension

1. The purpose of this modification is to update the Request for Quote due date of the November 2024 P&T drug classes as follows:

FROM: September 12, 2024 TO: September 19, 2024

2. All other terms and conditions remain the same.

Marsha L. Petersen Contracting Officer

2024-09-09T12:42:18-0500
PETERSEN.MARSHA.LISA.1021485299

File details come from the government source that posted it. Updated .